Quantcast
Last updated on April 23, 2014 at 15:57 EDT

Latest Didanosine Stories

2014-04-15 12:30:09

PITTSBURGH, April 15, 2014 /PRNewswire/ -- Mylan Inc. (Nasdaq: MYL) today confirmed that it and its partner Famy Care Ltd. have entered into a settlement and license agreement with Warner Chilcott Company, LLC, settling the parties' litigation in connection with Mylan's filing of an Abbreviated New Drug Application (ANDA) with the U.S. Food and Drug Administration (FDA) for Norethindrone and Ethinyl Estradiol Chewable Tablets 0.8 mg/0.025 mg and Ferrous Fumarate Chewable Tablets. This...

2014-03-25 00:23:18

DUBLIN, March 25, 2014 /PRNewswire/ -- Research and Markets ( http://www.researchandmarkets.com/research/rq8jml/investigation) has announced the addition of the "Investigation Report on China Montelukast Market" [http://www.researchandmarkets.com/research/rq8jml/investigation ] report to their offering. <start_newscom> (Logo: http://photos.prnewswire.com/prnh/20130307/600769 ) There are over 30 million people suffering from seasonal asthma of different...

FDA Approves Novel AstraZeneca, Bristol-Meyers Squibb Diabetes Drug
2014-01-10 11:37:58

Ranjini Raghunath for redOrbit.com - Your Universe Online The FDA has approved the use of a new Type 2 diabetes drug called Farxiga, developed by pharmaceutical companies Bristol-Meyers Squibb and AstraZeneca. Type 2 diabetes affects 24 million people in the US and nearly 350 million people worldwide. Conventional diabetes drugs work by reducing the amount of sugar the body absorbs from food or by boosting the production of insulin which disposes of excess sugar. Farxiga, however,...

2013-08-01 23:22:36

The CAI prioritized the NCI portfolio resulting in 50 near-term commercially viable inventions. The CAI will coordinate with small businesses, the biopharmaceutical industry and educational institutions to match these NCI technologies for possible collaboration and technology transfer. Bethesda, Maryland (PRWEB) August 01, 2013 The Center for Advancing Innovation, INC (CAI), a globally focused private-public partnership with an over-arching mission to drive successful innovation entered...

2013-05-03 08:25:40

SAN DIEGO, May 3, 2013 /PRNewswire/ -- Ambrx today entered into a collaboration agreement with Bristol-Myers Squibb (NYSE: BMY) for the discovery and development of novel antibody drug conjugates using Ambrx's protein medicinal chemistry technology. Under terms of the agreement, Ambrx will receive an upfront payment of $15 million, funding for discovery and research activities, and potential development, regulatory and sales based milestone payments of up to $97 million per product resulting...

2013-04-17 04:21:53

Patients to benefit from potential for improved efficacy in less commonly used types of ARV therapies and one-pill-daily combination drugs LONDON, April 17, 2013 /PRNewswire/ -- The anticipated launch of drugs currently in the pipeline, together with the introduction of oral combination pills, are set to have a profound impact on the European HIV drugs market. New analysis from Frost & Sullivan (http://www.lifesciences.frost.com), Analysis of the European HIV Drugs Market, finds...

2013-02-25 08:23:15

NEW YORK, February 25, 2013 /PRNewswire/ -- Today, National Traders Association announced new research reports highlighting Newmont Mining Corp (NYSE:NEM), AMETEK, Inc. (NYSE: AME), Honeywell International Inc. (NYSE: HON), Amgen, Inc. (NASDAQ:AMGN) and Bristol Myers Squibb Co. (NYSE:BMY). Today's readers may access these reports free of charge - including full price targets, industry analysis and analyst ratings - via the links below. Newmont Mining Corp Research Report...

2013-01-13 16:21:54

BELVEDERE, Calif., Jan. 14, 2013 /PRNewswire/ -- Du Molin & Du Molin, Inc. (DDI) venture capital group announces the newest product to emerge from its incubator after a beta test involving more than 700 participants. Code named 'LeadFire', the SaaS (software as a service) next generation lead gen platform was developed with $5M of DDI funding. It allows large online lead aggregation companies to customize, launch and manage organic lead generation campaigns for thousands...

2013-01-02 16:22:49

Amazon tree-derived medicine cleared for usage in HIV patients with diarrhea AUSTIN, Texas, Jan. 2, 2013 /PRNewswire-USNewswire/ -- The following is being released by the American Botanical Council: (Logo: http://photos.prnewswire.com/prnh/20100430/DC95601LOGO) On New Year's Eve of 2012, the US Food and Drug Administration (FDA) announced its approval of crofelemer (Fulyzaq(TM), Salix Pharmaceuticals, Ltd., Raleigh, North Carolina) -- marking the second time a botanical, and the first...

2012-10-17 11:24:22

EXTON, Pa., Oct. 17, 2012 /PRNewswire/ -- Absorption Systems, a world leader in developing novel test systems for pharmacokinetics and drug-drug interactions, announces the launch of ExpressPlus(TM) Transporters, a series of early-stage screening assays to detect interactions of new drug candidates with membrane proteins called transporters. ExpressPlus is a natural extension of Absorption Systems' proprietary cell-based test systems, CellPort Technologies®. The new drug transporter...